… Version October 2022 Who we are In this Notice, the words “ProQR”, “We”, “Us” and “Our” refer to ProQR Therapeutics … (DPO) regarding any information, or concerns, related to ProQR’s processing of personal data, by sending an e-mail …
At ProQR we take care to give all applicants a good experience and value their time and interest in applying to become a ProQRian. On this page, you can find an overview of what you can expect throughout the recruitment process, until your first onboarding week.
… Corporate governance Find all information regarding ProQR’s corporate governance including the articles of … Documentation Documentation Download link 20240523-ProQR Articles of Association (EN) pdf , 1.68 Mo Download …
ProQR's leadership is a strong team with proven track record. Find out who is on our management team, board of directors and scientific advisory board.
… Investors & Media ProQR Investor and Media page. Located in Leiden, Netherlands and Cambridge, Mass., ProQR Therapeutics (Nasdaq:PRQR) is a biotechnology company … through the creation of transformative RNA therapies. ProQR is pioneering a next-generation RNA technology called …
ProQR is pioneering a next-generation RNA technology called Axiomer™, which uses a cell’s own editing machinery called ADAR to make specific single nucleotide edits in RNA to reverse a mutation or modulate protein expression and could potentially yield a new class of medicines for both rare and prevalent diseases with unmet need.
Check out our vacancies! We are looking for people who are inspired by our mission to edit RNA, treat disease and change lives. Are you up for the challenge?
